HALO
Halozyme Therapeutics, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #542
- Final score
- 48.55
- Years on list
- 2
↗ Climbed 123 since 2025
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 123 since 2025
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 43 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 197 since 2021
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | HALO | VRTX | RPRX |
|---|---|---|---|
| Climate Change | 39.4 | 61.1 | 57.2 |
| Employee Relations | 55.6 | 53.4 | 51.4 |
| Environment | 65.3 | 40.6 | 17.7 |
| Stakeholders & Society | 29.0 | 41.1 | 68.2 |
| Human Rights | 42.0 | 46.3 | 42.0 |
| Governance | 52.1 | 40.4 | 46.5 |
| Performance Rating | 60.5 | 57.4 | 77.7 |